Two glycosylinositol phosphates related to putative insulin mimetics, 6-0-(2-amino-2-deoxy-a-~-glucopyranosy1)-D-chiro-inositol 1-phosphate (1) and 6-0-(2-amino-2-deoxy-a-~-glucopyranosyl)-~-myo-inositol 1-phosphate (2), have been synthesized from selectively protected and enantiomerically pure D-chiro-and myo-inositol derivatives. The D-chiro-inositol unit was prepared in a multigram scale from D-glucose using the Ferrier's carbocyclization route, and it was transformed into the corresponding my0 epimer by an oxidation-reduction sequence. The trichloroacetimidate method was applied efficiently for the key glycosylation of the inositol derivatives.
It has been proposed that the plasma membrane contains glycosylphosphatidylinositols (GPIs) which are cleaved by phosphatidylinositol specific phospholipase C (PI-PLC) or D (PI-PLD) to release phosphoinositol phosphoglycans or inositol phosphoglycans, respectively. These released glycans may act as mediators of a variety of enzyme pathways.l The most thoroughly studied system is the cleavage of GPI after binding of insulin in hepatocytes, adipocytes, or myocytes.2 Binding of insulin to these target cells results in the PI-PLC or PI-PLD mediated cleavage of a GPI to release a phosphoinositol phosphoglycan or inositol phosphoglycan, respectively, which seem to act as second messengers of insulin action.2 These compounds have also been reported to mediate the action of interleukine 2,3 insulin-like growth factor: and nerve growth factor.5
The precise chemical structure of these putative mediators has not been elucidated yet, but present evidence indicates that it could be related to those of the GPIs which anchor proteins, polysaccharides, or small oligosaccharides to the outer face of cellular membranes through a covalent linkage. 6 At least two structurally distinct mediators have been r e p~r t e d .~~~~ The first one inhibited CAMP-dependent protein kinase and contained myoinositol and chiro-inositol, 2-amino-2-deoxy-~-glucose, galactose, and phosphate.2i The second type stimulated the existence of a family of compounds with different biological activities rather than a unique phosphoglycan m e d i a t~r .~'~~ In agreement with this, we have recently determined partial structures of insulin mediators from bovine liver which contained a variable number of phosphorylated a-galactose residues, N-acetylglucosamine or -galactosamine, non-ZV-acetylated glucosamine, and inositol.*
The determination of the structure of this potentially important family of compounds is seriously hampered by the minute amounts of active material present in the biological sources from which they have to be isolated. The development of effective and versatile strategies for the preparation of building blocks which could be used for the synthesis of different structures required for biological experiments is, therefore, necessary. In this context, we are involved in work directed to establish these strategiesgJ0 and have reported on an efficient route leading to glycosylmyo-inositol 1-phosphate starting from myo-inositol.'Oa We have developed a different route for the synthesis of glycosyl-D-chiro-inositol 1-phosphates, that can also be used for the synthesis of glycosyl-myo-inositol l-phosphates, in which the inositol unit is prepared from D-glUCOSe.g We now report the synthesis of 6-0-(2-amino-2-deoxy-a-~-glucopyranosyl)-~-chiro-inositoll-phosphate (1) and 6-~-(2-am~no-2-deoxy-a-D-glucopyranosyl)-D-myoinositol 1-phosphate (2) following this synthetic strategy. The complete sequence leading to 1 has been optimized and permits the preparation of sufficient material to be used in biological investigation. Synthesis of several fragments and the complete glycosylphosphatidylinositol anchor of the variant surface glycoprotein of Trypanosoma brucei and of rat liver Thy-1 glycoproteinll as well as of related oligosaccharide fragments12 containing myo-or D-chiro-inositol have been described.
Results and Discussion
The synthesis of the conveniently functionalized D-chiroinositol derivative (10) is shown in Scheme 1. Enone 6: available in multigram amounts from methyl a-D-glucopyranoside by modification of a known procedure,13J4 was further transformed into the key epoxide 8 as reported by Acid-catalyzed trans-diaxial openingls of the epoxide ring of 8 with allyl alcohol in the presence of boron trifluoride etherate afforded the D-chiro-inositol derivative 9, which was transformed into 10 and 11 through tinmediated regioselective alkylation.16 In compound 10 positions 1 and 6 appear differentiated for further phosphorylation and glycosylation. The complete sequence constitutes an effective method for the multigram-scale preparation of conveniently substituted D-chiro-inositol derivatives in which the nature and position of the protecting groups can be varied at will and represents a further example of the usefulness of the Ferrier's cwbocyclization rea~ti0n.l~ The stereochemistry of 9 was unequivocally established (Scheme 1) by transformation into the previously knownls 1-0-methyl-D-chiro-inositol (13) and its penta-0-acetate 14.
Glycosylation of the axial hydroxyl group of a D-chiroinositol derivative has not been reported in the literature. However, a low reactivity was anticipated toward glycosyl donors bearing a nonparticipating nitrogen function at position 2, as required for the preparation of 1. According to previous experience,lob preliminary experiments indicated that the trichloroacetimidate pro~edure'~ gave the best yield and a-selectivity, and therefore, glycosyl donor 15 was used.12b This trichloroacetimidate was readily For the synthesis of the myo-inositol derivative 2 , several attempts were made to invert the configuration of the free hydroxyl group of 10 or 11 conventionally, either through a Mitsunobu reactionz4 or by treatment of the corresponding triflate with benzoyl n u~l e o p h i l e s~~ with unsatisfactory results. Similarly, the attempted osmylation of 7 did not provide a convenient route for the gramscale preparation of the desired myo-inositol compound. Therefore, a two-step oxidation-reduction sequence was preferred (Scheme 3). Thus, oxidation of either 10 or 11 gave the corresponding ketones whose reduction was strongly dependent on steric and electronic factors. Lithium reagents seemed to favor a-delivery of hydride and only reducing agents bearing very large alkyl substituents favored @-attack, away from the vicinal allyloxy group in axial position, providing the desired stereochem- istry (Table 1) . Most likely, the orientation of the substituents a to the carbonyl function in the ketones allows complexation of these molecules by both faces. The configuration of 19 was unequivocally established by conversion into the previously known (-)-bornesitol (20) and its penta-0-acetate 21 (Scheme 3).% Phosphorylation of 19 gave 22 and subsequent acidolysis of the pmethoxybenzyl group afforded the myo-inositol derivative 23, which is ready for glycosylation at position 6 (Scheme 4). Reaction of 23 with trichloroacetimidate 15, using TMSOTf as promotor, afforded glycoside 24 in 65 5% yield, which was completely deprotected to give 212a*d@ in moderate yield (Scheme 4).
Experimental Section
General. NMR and are uncorrected. Optical rotations were determined with a Perkin-Elmer 141 polarimeter. Elemental analyses were obtained with a Perkin-Elmer 240 instrument. Separation and purification of products was performed by flash chromatography using silica gel Merck (230-400 mesh). Silica gel plates (Merck, GFm) were used for analytical thin-layer chromatography (TLC). Tetrahydrofuran (THF) and ethyl ether were distilled under argon from sodium-benzophenone, methylene chloride from calcium hydride, and dimethylformamide from barium oxide. All reactions were performed under an argon atmosphere with anhydrous, freshly distilled solvents, unless otherwise indicated.
Methyl 2,3,4-Tri-Obenzyl-a-~glucopyranoeide (4).l3 To asolution of methyl a-D-glucopyranoside (3, 19 .40 g, 100.00 mmol) in pyridine (200 mL) were added TrCl (35.00 g, 125.67 mmol) and DMAP (2.00 g, 16.37 mmol). After 16 h, the solvent was evaporated, and the residue was crystallized (EtOH, 200 mL).
The resulting crystalline methyl 6-O-trityl-a-~-glucopyranoside (36.34 g, 83%) was dissolved in DMF (400 mL) and treated with 95% NaH (15.00 g, 606.25 mmol) and BnBr (60 mL, 86.34 g, 504.91 mmol) a t rt. After 3 h, the reaction was quenched with MeOH (150 mL), and the solvents were evaporated at reduced pressure. The residue was dissolved in E t 0 (900mL) and washed with HoO (500 mL). The aqueous phase was extracted with Et20 (2 X 250 mL), and the combined organics were washed with brine (200 mL), dried (NazSO4), and concentrated. The resulting residue was dissolved in MeOH-CH2C12 (2:1, 500 mL), and p-TsOH was added until pH < 4. After 12 h of stirring, the reaction was neutralized with EtsN, and the solvents were evaporated. E t 0 (400 mL) was added, and the organic phase was washed with Ha0 (500 mL). The aqueous phase was extracted with EtzO (2 X 100 mL), and the combined organics were washed with brine (200 mL), dried (Na2SO4), and concentrated. The Methyl 2,3,4-Tri-0benzyl-cu-~-xyl~ hex-6-enopyranoside (6).14 To a solution of 3 (42.10 g, 90.73 mmol) in pyridine (500 mL) were added Ph3P (68.00 g, 259.54 mmol) and CL (68.00 g, 130.77 mmol). After 12 h, MeOH (120 mL) was added and the solvents were evaporated. The residue was dissolved in E t 0 (500 mL) and washed with HzO (300 mL). The aqueous phase wasextractedwithEtO(3 X 100mL),andthecombinedorganics were washed with brine (200 mL), dried (NaZSOd), and concentrated. The resulting residue was purified by flash chromatography (hexane/AcOEt 20:l -S l ) , affording methyl 2,3,4-tri-O-benzyl-6-iodo-6-deoxy-a-~-glucopyranoside (38.50 g, 74 % ). This product was dissolved in DMF (350 mL) and treated with 95% NaH (9.60 g, 380.00 mmol). After 20 h, MeOH (200 mL) was added, the solvent was evaporated at reduced pressure, and the resulting residue was suspended in H20 (200 mL). The aqueous phase was extracted with E t 0 (2 X 300 mL), the combined organics were washed with brine (200 mL), dried (NazSOd), and concentrated, and the resulting residue was purified by flash chromatography (hexane/AcOEt 15:l-c lOl), affording 614 (25.50 g, 63% from 3). (2S,3R,45)-2,3,4-Trie(benzyloxy)cyclohex-S-enone (6) .14 To a solution of 6 (12.00 g, 26.91 mmol) in Me2CO-H*0 (2:1,800 mL) was added HgCl2 (7.90 g, 29.10 mmol), and the resulting solution was heated at 100 "C for 90 min. The reaction was then cooled, and the solvent was evaporated at reduced pressure. The residue was dissolved in E t 0 (300 mL) and washed with 10% aqueous KI (300 mL). The aqueous phase was extracted with EtzO (3 X 100 mL), and the combined organics were washed with brine (200 mL), dried (Na2SO,), and concentrated. The resulting residue was purified by flash chromatography (hexane/AcOEt J. Org. Chem., Vol. 59, No. 11, 1994 3139 3:1) , affording a mixture of epimers (9.88 g, 85%, a/p = 3.51 by lH NMR). To a solution of this mixture (6.30 g, 14. 58 mmol) in pyridine (120 mL) were added MsCl (3 mL, 38.8 mmol) and DMAP (250 mg, 2.05 mmol). After 4 h, ice (100 g) was added, and the aqueous phase was extracted with EkO (3 x 100 mL).
The solvents were evaporated at reduced pressure, and the resulting residue was purified by flash chromatography (hexane/ AcOEt 1 0 1 -4:1), affording 614 (4.86 g, 68% from 5).
1,2,3-Tri-O-benzylconduritol B (7).
To a solution of 6 (4.86 g, 11.74 mmol) in MeOH (450 mL) at -50 "C was added CeClr7H20 (4.60g, 12.35mmol). After 10min of stirring, NaBH4 (700 mg, 18.42 mmol) was added, and the reaction mixture was stirred at -50 0C for 5 h. The reaction mixture was treated with MezCO (5 mL) at -50 "C and allowed to warm tort. The solvents were evaporated at reduced pressure and the resulting residue was dissolved in EkO (100 mL) and washed with H2O (100 mL).
The aqueous phase was washed with Et20 (100 mL), and the combined organics were concentrated, affording an epimeric mixture of alcohols (4.70 g, 97%, 14:l by lH NMR), which was submitted to epoxidation without further purification. A pure sample of 7 was obtained by flash chromatography (hexanel AcOEt 4:l-2:l): mp 116-119 "c; [(u 
4,5,6-Tri-O-benzyl-l,2-anhydro-myo-inositol (8).
To a solution of 7 (4.70 g, 11.30 mmol) in CHzClz (120 mL) was added 55% m-CPBA (5.32 g, 16.97 mmol) at rt. After 24 h, CHzClz (80 mL) was added, and the organic phase was washed with 10% Na2S2O3 (100 mL) and saturated aqueous NaHCO3 (100 mL). The solvent was evaporated at reduced pressure, and the resulting residue was purified by flash chromatography (hexane/AcOEt 
1-O-Allyl-2,3,4-tri-O-benzyl-~-ch~ro-inositol (9).
To a solution of 8 (4.55 g, 10.53 mmol) in CHzCl2 (100 mL) were added allyl alcohol (4.69 mL, 68.81 mmol) and BFrOEb (2.70 mL, 21.94 mmol). After 3.5 h, the reaction was neutralized with EtsN, CH2C12 (100 mL) was added, and the organic phase was washed with water (150 mL). The organic layer was dried (NazSO4) and evaporated at reduced pressure, and the resulting residue was purified by flash chromatography (hexane/AcOEt 2:l-1:l) to give 9 as a syrup (3.87 g, 75%): (50 MHz, 127.7, 127.6, 127.5, 127.4, 117.1, 81.6, 81.5, 80.2, 75.6, 75.5, 75.3, 73.1, 72.5, 71.3, 69.5. Anal. Calcd for C30HMOS: C, 73.45; H, 6.99. Found: C, 73.12; H, 6 .87.
1-OAllyl-2,3,4,5-tetra-O-benzyl-~-ch~~inositol(lO).
To a solution of 9 (275 mg, 0.561 mmol) in MeCN (20 mL) were added BuzSnO (145 mg, 0.582 mmol), Bu4NBr (185 mg, 0.574 mmol), powdered 3-A molecular sieves (2.0 g), and BnBr (0.33 mL, 2.77 mmol), and the resulting solution was heated at 80 "C. After 5 h, the reaction was cooled and filtered through a pad of Celite. The filter was washed with CHzCl2 (2 X 10 mL), and the filtrate and washings combined were evaporated at reduced pressure. The resulting residue was purified by flash chromatography (hexane/AcOEt 4:1,2.7 X 14.0 cm) to give 10 as a syrup (270 8,138.7,138.5,135.0,128.6,128.3,128.1,128.0,127.9, 139.0,138.95,138.7,138.1,135.1,128.5,128.3,128.0,127.9,127.7,  127.4,116.8,81.9,81.6,80.3,79.9,75.8,75.7,75.6,73.3,72.5,68.2.  1,2,3,4,5-Penta-O-benzyl-D-chiro-inositol(12) . To a solution of 9 (590 mg, 1.20 mmol) in DMF (20 mL) were added 80% NaH (180 mg, 6.00 mmol) and BnBr (0.72 mL, 6.06 mmol) at rt. After 90 min, MeOH (0.5 mL) was added and the solvents were evaporated at reduced pressure. The residue was dissolved in CHzCl2 (30 mL) and washed with HzO (20 mL). The organic layer was dried (Na~S04) and concentrated. The crude was dissolved in 95% EtOH (60 mL), treated with 10% Pd/C (320 mg) and p-TsOH (65 mg), and heated at 80 "C.% After being stirred for 2 h at 80 "C, the reaction was cooled to rt and filtered through a pad of Celite, washing with CHzClz (20 mL) and MeOH (20mL). The fiitrateand the washingscombined wereevaporated at reduced pressure, and the resulting residue was purified by flash chromatography (hexane/AcOEt 5:l) to give 12 (410 mg, 54%).
1-0-Methyl-D-chiro-inositol ( 13).18 To a solution of 12 (410 mg, 0.651 mmol) in DMF (15 mL) were added 80% NaH (39 mg, 1.30 mmol) and Me1 (0.1 mL, 1.62 mmol). After 15 min, MeOH (0.1 mL) was added, and the solvents were evaporated at reduced pressure. The residue was dissolved in CHzCl2 (15 mL) and the solution was washed with HzO (15 mL), dried (Na2S04), and concentrated at reduced pressure. The crude was dissolved in MeOH (40 mL), 10% Pd/C (168 mg) wasadded, and the mixture was stirred under Hz (1 atm) at rt. After 14 h, the reaction mixture was filtered through a pad of Celite, the filter was washed with MeOH (2 X 15 mL), and the filtrate and washings combined were evaporated at reduced pressure. The resulting reeidue was purified by flash chromatography (CH2CldMeOH 2:1,2.7 X 10.5 cm) to give 13 (80mg, 63% ): 6,169.55, 169.5,169.35,169.3, 76.9, 71.3, 70.9, 70.5, 69.7, 67.6, 59.0, 20.2, 19.9. 6-OAcetyl-2-azido-3,4-di-O-benzyl-2-deoxy-~-D-glucopyranosyl Trichloroacetimidate ( 15).12b To a solution of 6-0-acetyl-2-azido-3,4-di-O-~nzyl-2-deoxy-~-~-glucopyranose~~~ (200 mg, 0.47 mmol) and CCbCN (680 mg, 4.71 mmol) in 3 mL of CH2C12 was added powdered, flame-dried KzCO3 (65 mg, 0.47 mmol) at 23 "C. After 1 h of stirring, the suspension was filtered through a pad of Celite and the filtrate was concentrated at reduced pressure. The residue was quickly purified by flash chromatography (hexane/EtOAc 3:l) to give 15 as a white solid (262 mg, 98%, >95% fi anomer by lH NMR).
1-(6-O-Acetyl-2-azido-2-deoxy-3,4-dibenzyl-(u-~-glucopyranosyl)-6-~~~l-2,3,4~-tetra-~benzyl-~-c~inosito~(l6). A mixture of 10 (214 mg, 0.37 mmol) and 15 (137 mg, 0.23 mmol), azeotroped with freshly distilled benzene (2 X 10 mL), was dissolved in CH2Clp (3 mL). The solution was cooled to -25 OC and treated with CF3SOzSiMe3 (95 pL of a 0.2 M solution in C&C1~,0.019 mmol). After being stirred at -25 "C for 30 min, the solution was allowed to warm to rt over 3 h, and EtsN (0.6 mL), AczO (0.2 mL), and DMAP (5 mg) were added. After 4 h of stirring, MeOH (0.5 mL) was added, the solution was stirred for 5 min, and the solvent was removed at reduced pressure. The residue was purified by flash chromatography (hexane/EtOAc 9:1-5:l) to give 16 as a colorless syrup (124 mg, 55%): [(uIz3D J~10.1,3.5),1.67(~,3H);'3C(50MH~,C~~)6169.6,139.8,  139.7, 138.8, 138.4, 135.4, 128.5-127.5 (obscured by solvent  signals), 116.6, 96.5, 82.4, 80.6, 80.5, 78.6, 78.5, 76.0, 75.7, 75.3 1-( 6-O-Acetyl-2-azido-2-deoxy-3,4-dibenzyl-~~-~-glucopyranosyl)-2,3,4,5-tetra-O-benzyl-~-c~~inositol (17). To a solution of 16 (124 mg, 0.125 mmol) in THF (4 mL) under argon was added [Ir(COD)(PhzMeP)z]PFe (4 mg, 4.8 X 1V mmol) at rt. The argon atmosphere was replaced with Hz and the solution was stirred for 5 min, during which time the initially slightly red suspension becomes colorless. The Hz was replaced with argon again, the solution was stirred for 1 h, and water (1.0 mL) and 1 2 (74 mg) were added. After 2 h of stirring, the reaction mixture was diluted with EtOAc (25 mL), washed with 10% aqueous NazSz03 (20 mL) and brine (10 mL), dried (NazSOd), and concentrated at reduced pressure. was diluted with water (0.5 mL) and treated with NaIO, (68 mg, 0.40 mmol) and RuCla-BHzO (0.5 mg). After being stirred vigorously for 1 h, the reaction mixture was diluted with CHzClz (25 mL) and washed with water (10 mL). The aqueous layer was extracted with CHzClz (2 x 20 mL). The combined organic extracts were dried (NazSO4) and concentrated at reduced pressure. The residue was purified by flash chromatography (hexane/EtOAc 3:l -32) to give 18 as a colorless oil (88 mg, 6 Hz) . A solution of the latter compound (147 mg, 0.126 mmol) in MeOH (15 mL) and 0.2 M NaOAc/HOAc pH 5 buffer (15 mL) was stirred under Hz (1 atm) in the presence of 10% Pd/C (100 mg) at rt. After 18 hof stirring, the suspension was filtered through a pad of Celite and the filtrate was passed through a column of Na-exchanged Amberlite IR-120. The resultant solution was lyophilized and the residue was purified by column chromatography on Sephadex G-15 (HzO) to give 1 as a white solid (34 mg, 40% from 18): [a] ), and PMBCl(4.00 mL, 29.52 mmol), and the resulting solution was heated at 80 ' C. After 5 h, the reaction was cooled and filtered through a pad of Celite. The filter was washed with CHzCl2 (2 X 40 mL), and the fitrate and washings combined were evaporated at reduced pressure. Allyl-3,4,5-tri-O-benzyl-6-O-~methoxybenzyl)-myoinositol (19) . To a solution of 11 (3.39 g, 5.56 "01) in CHzClz (80 mL) was added PCC (2.72 g, 12.62 mmol) at rt. After being stirred for 13 h, the reaction mixture was filtered through a pad of Celite, the filter was washed with CHZClz (2 X 25 mL), and the filtrate and washings combined were evaporated at reduced pressure. The resulting residue was purified by flash chromatography (hexane/AcOEt 81 -41) to give the ketone as a colorless syrup (3.00 g, 89%) . To a solution of the ketone (3.00 g, 4.93 "01)
1H,
in THF (100 mL), at -90 "C, was added a solution of (R)-Alpine hydride (0.5 M in THF, 21.0 mL, 10.50 mmol) in THF (40 mL). After 30 min, the reaction was warmed to 0 OC, and water (46 mL), 3 M NaOH (14 mL), and 30% HzOz (30 mL) were added. After 30 min, the reaction was warmed to 22 "C, HzO (250 mL) was added, the aqueous phase was extracted with E t 0 (2 X 250 mL), and the solvent was evaporated at reduced pressure. The resulting residue was purified by flash chroma- After being stirred for 1.5 h at rt, the reaction mixture was cooled to 0 "C and HzO (2.5 mL), NdO4 (300 mg, 1.39 mmol) and RuC13.3Hz0 (1 mg) were added. The resulting mixture was vigorously stirred at 0 "C for 0.5 h. The reaction mixture was diluted with CHzCll (60 mL), washed with 10% aqueous NazSzOa (10 mL), and brine (10 mL), dried (Na#O4), and evaporated at reduced pressure. 
2-OAllyl-3,4,5-tri-Obenzyl-l-O(dibenzylphosphono)-~-myo-inositol (23).
To a solution of 22 (100 mg, 0.11 mmol) in CHzClz (1 mL) was added CF3COzH (2 mL of a 2.5% v/v solution in CH2C12) at 23 "C. After being stirred for 1 h at room temperature, the reaction mixture was diluted with CHzClz (25 mL) and washed with saturated aqueous NaHCOs, the aqueous phase was extracted with CHzClz (3 X 20 mL), the combined
